CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding

Autor: Mason S, Lu Ls, Boyd Rs, P J Adam, A C Stamps, Graham Steers, K C Gatter, Leach Bi, Stockwin L, Francesco Pezzella, G C Fletcher, J A Loader, Jonathan Alexander Terrett, Adrian L. Harris

Publikováno v: British Journal of Cancer

In order to identify potential markers of renal cancer, the plasma membrane protein content of renal cell carcinoma (RCC)-derived cell lines was annotated using a proteomics process. One unusual protein identified at high levels in A498 and 786-O cel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::741c4c8736c4c555723bd311c401758b
http://europepmc.org/articles/PMC2360640

Correction to: Cryo-Fluorescence Tomography as a Tool for Visualizing Whole-Body Inflammation Using Perfluorocarbon Nanoemulsion Tracers.

Autor: Leach BI; Department of Radiology, University of California, San Diego, La Jolla, CA, 92093, USA., Lister D; Invicro LLC, Needham, MA, 02494, USA., Adams SR; Department of Pharmacology, University of California, San Diego, La Jolla, CA, 92093, USA., Bykowski J; Department of Radiology, University of California, San Diego, La Jolla, CA, 92093, USA., Schwartz AB; Department of Radiology, University of California, San Diego, La Jolla, CA, 92093, USA., McConville P; Invicro LLC, Needham, MA, 02494, USA., Dimant H; Invicro LLC, Needham, MA, 02494, USA., Ahrens ET; Department of Radiology, University of California, San Diego, La Jolla, CA, 92093, USA. etanospam@gmail.com.

Publikováno v: Molecular imaging and biology [Mol Imaging Biol] 2024 Oct; Vol. 26 (5), pp. 899.

Conformational Dynamics of an Amyloidogenic Intermediate of Transthyretin: Implications for Structural Remodeling and Amyloid Formation.

Autor: Leach BI; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA., Ferguson JA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA., Morgan G; Departments of Chemistry and Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA., Sun X; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA., Kroon G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA., Oyen D; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA., Dyson HJ; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA., Wright PE; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA; Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. Electronic address: wright@scripps.edu.

Publikováno v: Journal of molecular biology [J Mol Biol] 2024 Aug 15; Vol. 436 (16), pp. 168673. Date of Electronic Publication: 2024 Jun 21.

Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma receiving tumor-infiltrating lymphocytes labeled with perfluorocarbon nanoemulsion.

Autor: Ahrens ET; Department of Radiology, University of California San Diego, La Jolla, California, USA eahrens@ucsd.edu., Helfer BM; Celsense, Pittsburgh, Pennsylvania, USA., O'Hanlon CF; Lot 49 Consulting, Pittsburgh, Pennsylvania, USA., Lister DR; Department of Radiology, University of California San Diego, La Jolla, California, USA., Bykowski JL; Department of Radiology, University of California San Diego, La Jolla, California, USA., Messer K; Division of Biostatistics, University of California San Diego, La Jolla, California, USA., Leach BI; Department of Radiology, University of California San Diego, La Jolla, California, USA., Chen J; Department of Electrical and Computer Engineering, University of California San Diego, La Jolla, California, USA., Xu H; Department of Radiology, University of California San Diego, La Jolla, California, USA., Daniels GA; Department of Medicine, University of California San Diego, La Jolla, California, USA., Cohen EEW; Department of Medicine, University of California San Diego, La Jolla, California, USA.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jun; Vol. 11 (6).

Assessing Oximetry Response to Chimeric Antigen Receptor T-cell Therapy against Glioma with ¹⁹ F MRI in a Murine Model.

Autor: Chapelin F; Department of Biomedical Engineering, University of Kentucky, Lexington, Ky (F.C.); Department of Radiology (B.I.L., D.L., E.T.A.), Department of Biostatistics and Bioinformatics (R.C.), and Department of Family Medicine and Public Health (K.M.), University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093; Department of Neurologic Surgery, University of California San Francisco, San Francisco, Calif (H.O.); and Parker Institute for Cancer Immunotherapy, San Francisco, Calif (H.O.)., Leach BI; Department of Biomedical Engineering, University of Kentucky, Lexington, Ky (F.C.); Department of Radiology (B.I.L., D.L., E.T.A.), Department of Biostatistics and Bioinformatics (R.C.), and Department of Family Medicine and Public Health (K.M.), University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093; Department of Neurologic Surgery, University of California San Francisco, San Francisco, Calif (H.O.); and Parker Institute for Cancer Immunotherapy, San Francisco, Calif (H.O.)., Chen R; Department of Biomedical Engineering, University of Kentucky, Lexington, Ky (F.C.); Department of Radiology (B.I.L., D.L., E.T.A.), Department of Biostatistics and Bioinformatics (R.C.), and Department of Family Medicine and Public Health (K.M.), University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093; Department of Neurologic Surgery, University of California San Francisco, San Francisco, Calif (H.O.); and Parker Institute for Cancer Immunotherapy, San Francisco, Calif (H.O.)., Lister D; Department of Biomedical Engineering, University of Kentucky, Lexington, Ky (F.C.); Department of Radiology (B.I.L., D.L., E.T.A.), Department of Biostatistics and Bioinformatics (R.C.), and Department of Family Medicine and Public Health (K.M.), University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093; Department of Neurologic Surgery, University of California San Francisco, San Francisco, Calif (H.O.); and Parker Institute for Cancer Immunotherapy, San Francisco, Calif (H.O.)., Messer K; Department of Biomedical Engineering, University of Kentucky, Lexington, Ky (F.C.); Department of Radiology (B.I.L., D.L., E.T.A.), Department of Biostatistics and Bioinformatics (R.C.), and Department of Family Medicine and Public Health (K.M.), University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093; Department of Neurologic Surgery, University of California San Francisco, San Francisco, Calif (H.O.); and Parker Institute for Cancer Immunotherapy, San Francisco, Calif (H.O.)., Okada H; Department of Biomedical Engineering, University of Kentucky, Lexington, Ky (F.C.); Department of Radiology (B.I.L., D.L., E.T.A.), Department of Biostatistics and Bioinformatics (R.C.), and Department of Family Medicine and Public Health (K.M.), University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093; Department of Neurologic Surgery, University of California San Francisco, San Francisco, Calif (H.O.); and Parker Institute for Cancer Immunotherapy, San Francisco, Calif (H.O.)., Ahrens ET; Department of Biomedical Engineering, University of Kentucky, Lexington, Ky (F.C.); Department of Radiology (B.I.L., D.L., E.T.A.), Department of Biostatistics and Bioinformatics (R.C.), and Department of Family Medicine and Public Health (K.M.), University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093; Department of Neurologic Surgery, University of California San Francisco, San Francisco, Calif (H.O.); and Parker Institute for Cancer Immunotherapy, San Francisco, Calif (H.O.).

Publikováno v: Radiology. Imaging cancer [Radiol Imaging Cancer] 2021 Jan 22; Vol. 3 (1), pp. e200062. Date of Electronic Publication: 2021 Jan 22 (Print Publication: 2021).